Repligen Corp. Company Profile (NASDAQ:RGEN)

Analyst Ratings

Consensus Ratings for Repligen Corp. (NASDAQ:RGEN) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $28.00 (0.54% upside)

Analysts' Ratings History for Repligen Corp. (NASDAQ:RGEN)
Show:
DateFirmActionRatingPrice TargetActions
6/13/2016Jefferies GroupReiterated RatingHold$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Craig HallumInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Repligen Corp. (NASDAQ:RGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q116$0.10$0.12$22.54 million$25.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415$0.07$0.07$19.84 million$21.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315$0.08$0.08$20.50 million$19.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215$0.08$0.11$20.05 million$21.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.07$0.09$18.20 million$20.82 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2015Q414$0.04($0.01)$14.70 million$15.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314$0.04$0.04$15.60 million$15.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q114$0.06$0.09$14.90 million$15.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q1$0.07$0.13$15.14 million$16.33 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q413$0.14$0.10$15.88 million$10.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313$0.13$0.18$16.27 million$18.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013$0.10$0.14$15.97 million$17.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.07$12.82 million$16.46 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312$0.06$8.63 million$15.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Repligen Corp. (NASDAQ:RGEN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.10$0.10$0.10
Q2 20161$0.12$0.12$0.12
Q3 20161$0.11$0.11$0.11
Q4 20161$0.12$0.12$0.12
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Repligen Corp. (NASDAQ:RGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Repligen Corp. (NASDAQ:RGEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/30/2016Thomas F Ryan JrDirectorSell5,000$26.60$133,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2016Thomas F Ryan JrDirectorSell10,000$24.59$245,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Howard BenjaminVPSell2,889$26.72$77,194.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Howard BenjaminVPSell35,000$38.14$1,334,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Walter C HerlihyCEOSell104,569$37.94$3,967,347.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2015Thomas F Ryan JrDirectorSell20,000$37.19$743,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Walter C HerlihyCEOSell24,536$31.78$779,754.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015James R RuscheSVPSell14,650$33.30$487,845.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Thomas F Ryan JrDirectorSell10,000$32.62$326,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Walter C HerlihyCEOSell49,695$33.08$1,643,910.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Howard BenjaminVPSell15,795$32.63$515,390.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Walter C HerlihyCEOSell51,386$23.43$1,203,973.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Thomas F Ryan JrDirectorSell10,000$23.81$238,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Howard BenjaminVPSell30,000$23.56$706,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Michael A GriffithDirectorSell23,342$22.90$534,531.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Howard BenjaminVPSell40,000$20.34$813,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2014Thomas F Ryan JrDirectorSell10,000$22.41$224,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2014Thomas F Ryan JrDirectorSell10,000$21.78$217,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014Walter C HerlihyCEOSell60,335$20.11$1,213,336.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014James R RuscheSVPSell30,000$20.19$605,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Daniel P WittSVPSell47,709$20.56$980,897.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2014Daniel P WittSVPBuy10,000$3.05$30,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013James R RuscheSVPSell30,000$10.01$300,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Karen A DawesDirectorBuy1,000$7.70$7,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013Thomas F Ryan JrDirectorSell21,000$8.97$188,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Thomas F Ryan JrDirectorSell86,039$9.01$775,211.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Walter C HerlihyCEOSell40,000$8.97$358,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2012Glenn L Md CooperDirectorBuy10,000$6.09$60,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2012Michael A GriffithDirectorBuy2,000$4.88$9,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Repligen Corp. (NASDAQ:RGEN)
DateHeadline
07/27/16 06:31 PMShort Interest Moves 24% Higher For RGEN
07/27/16 07:08 AMRepligen to Report Second Quarter 2016 Financial Results - [at noodls] - WALTHAM, Mass., July 27, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report second quarter 2016 financial results on Thursday, August 4, 2016. The ...
07/22/16 09:03 AMEarnings Focus and Crowd Sourced Sentiment Review for Repligen Corporation (NASDAQ:RGEN) - TGP
07/22/16 09:03 AMRepligen Corporation (NASDAQ:RGEN) Shorted Shares Increased 6.07% After Market Selling - Consumer Eagle
07/19/16 07:05 AMShares Lower on the Year Repligen Corporation (NASDAQ:RGEN) - Press Telegraph
07/19/16 07:05 AMRepligen Corporation (NASDAQ:RGEN) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/19/16 07:05 AMShare Performance Summary for: Repligen Corporation (NASDAQ:RGEN) - Press Telegraph
07/19/16 07:05 AMRepligen Corporation (NASDAQ:RGEN) Short Interest Decreased By 1.84% - Press Telegraph
07/19/16 07:05 AMWhat's The Growth Forecast For Repligen Corporation (NASDAQ:RGEN)? - RealistInvestor.com
07/17/16 05:32 PMShares Experiencing a Downtrend: Repligen Corporation (NASDAQ:RGEN) - TGP
07/17/16 05:32 PMShares Moving Down on the Week: Repligen Corporation (NASDAQ:RGEN) - Engelwood Daily
07/17/16 05:32 PMReview on Stock Valuation for: Repligen Corporation (NASDAQ:RGEN) - TGP
07/17/16 05:32 PMNext Weeks Broker Price Targets For Repligen Corporation (NASDAQ:RGEN) - Fiscal Standard
07/14/16 06:22 PMBearish Chart Formation for Repligen Corporation After Forming Bearish Multiple Bottom Pattern - Consumer Eagle
07/12/16 06:23 PMStock Moving Up This Week: Repligen Corporation (NASDAQ:RGEN) - Telanagana Press
07/12/16 06:23 PMRepligen Corporation (NASDAQ:RGEN) Sellers Covered 1.84% of Their Shorts - Consumer Eagle
07/11/16 10:45 AMStock on the Rise for the Quarter: Repligen Corporation (NASDAQ:RGEN) - Engelwood Daily
07/11/16 10:45 AMCompany Stock Focus for Repligen Corporation (NASDAQ:RGEN): Which Way Will Shares Head? - Press Telegraph
07/11/16 10:45 AMIs $44 Within Reach For Repligen Corporation (NASDAQ:RGEN)? - Investor Newswire
07/11/16 10:45 AMStock Performance Rundown on: Repligen Corporation (NASDAQ:RGEN) - Press Telegraph
07/11/16 10:45 AMRepligen Corporation (NASDAQ:RGEN)'s Growth Projection - RealistInvestor.com
07/09/16 09:13 AMBroker Outlook For Repligen Corporation (NASDAQ:RGEN) - Fiscal Standard
07/06/16 06:25 PMStock Accelerating: Repligen Corporation (NASDAQ:RGEN) - Telanagana Press
07/06/16 06:25 PMRepligen: Ready For More Upside - Seeking Alpha
07/06/16 10:45 AMStock Rating Watch and Earnings Insight for Repligen Corporation (NASDAQ:RGEN) - Press Telegraph
07/05/16 05:50 PMRepligen Corp (NASDAQ:RGEN) Stock Sentiment Increases - Engelwood Daily
07/04/16 10:45 AMStock Valuation in Review: Repligen Corporation (NASDAQ:RGEN) - Telanagana Press
07/04/16 10:45 AMShare Performance Recap for: Repligen Corporation (NASDAQ:RGEN) - Press Telegraph
07/04/16 10:45 AMRepligen Corporation (NASDAQ:RGEN) Receives Update on Growth Forecast - RealistInvestor.com
07/02/16 05:41 PMDirector of Repligen Corporation (NASDAQ:RGEN), Ryan Thomas F Jr, sells 5,000 shares worth $133,010
07/01/16 06:06 PMInsider Activity – Repligen Corporation (NASDAQ:RGEN)
07/01/16 06:06 PMDirector of Repligen Corporation (NASDAQ:RGEN), Ryan Thomas F Jr, sells 10,000 shares worth $245,888
07/01/16 04:23 PMRepligen Corp. – Value Analysis (NASDAQ:RGEN) : July 1, 2016 -
07/01/16 08:53 AMRepligen Corporation (RGEN) is Trading Higher on Unusual Volume for June 29 - Equities.com
06/30/16 06:23 PMRepligen Corporation (NASDAQ:RGEN) Company Rating and Target Watch - Telanagana Press
06/30/16 07:45 AMRepligen (RGEN) in Focus: Stock Adds 6.9% in Session -
06/30/16 07:17 AMRepligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : June 30, 2016 -
06/29/16 08:54 AMRepligen Corporation (NASDAQ:RGEN) Sellers Covered 1.84% of Their Shorts - Engelwood Daily
06/29/16 08:54 AMRepligen Corporation (NASDAQ:RGEN) Target Price Is $35.25 - RealistInvestor.com
06/29/16 08:54 AMShare Update and Earnings Review for Repligen Corporation (NASDAQ:RGEN) - Press Telegraph
06/24/16 06:12 PMRegeneron Pharmaceuticals, Inc. versus Repligen Corporation Head to Head Compare - CML News
06/22/16 06:05 PMNew Broker Ratings For Repligen Corporation (NASDAQ:RGEN) - FTSE News
06/22/16 10:51 AMRepligen Corporation Stock Momentum Hits Extreme Weakness - CML News
06/22/16 10:51 AMRepligen Corporation (RGEN) Jumps 6.19% on June 20 - Equities.com
06/22/16 10:51 AMHot News: Repligen Corporation (NASDAQ:RGEN), 3M Company (NYSE:MMM), Bristol-Myers Squibb Company ... - KC Register
06/09/16 06:34 PMRepligen Corporation (NASDAQ:RGEN) Fundamental Star Rating Report - CML News
06/06/16 06:03 PMREPLIGEN CORPORATION (NASDAQ:RGEN) Financial Condition Compared to S&P 500 - CML News
06/02/16 06:34 PMBuy, Sell Or Hold Rating For Repligen Corporation (NASDAQ:RGEN)? - Share Trading News - Buy, Sell Or Hold Rating For Repligen Corporation (NASDAQ:RGEN)?Share Trading NewsRepligen Corporation has a 50 day moving average of 26.22 and a 200 day moving average of 26.05. The stock's market capitalization is 812.69M, it has a 52-week low of 20.07 and a 52-week high of 42.48. The share price of the company (NASDAQ:RGEN) ...
06/02/16 09:07 AMRepligen to Present at Jefferies 2016 Healthcare Conference - GlobeNewswire (press release) - Repligen to Present at Jefferies 2016 Healthcare ConferenceGlobeNewswire (press release)WALTHAM, Mass., June 02, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs, today announced that Tony J. Hunt, Chief ...and more »
06/02/16 06:55 AMRepligen to Present at Jefferies 2016 Healthcare Conference - [at noodls] - WALTHAM, Mass., June 02, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs, today ...

Social

About Repligen Corp.

Repligen Corp. logoRepligen Corporation is a bioprocessing company. The Company is focused on the development, production and commercialization of products used in the process of manufacturing biologic drugs (bioprocessing). The Company is a manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing to separate and purify monoclonal antibodies, a type of biologic drug. The Company also supplies several growth factor products, Alternating Tangential Flow (ATF) System products and cell filtration products used to increase cell culture productivity during the bioproduction process. The Company has developed a series of OPUS chromatography columns for use in clinical-scale manufacturing. The Company manufactures and sells Protein A and growth factors to life sciences companies under long-term supply agreements and sells its chromatography columns, as well as media and quality test kits.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RGEN
  • CUSIP: 75991610
Key Metrics:
  • Previous Close: $27.85
  • 50 Day Moving Average: $25.57
  • 200 Day Moving Average: $25.31
  • P/E Ratio: 116.58
  • P/E Growth: 2.37
  • Market Cap: $941.19M
  • Beta: 1.35
  • Current Year EPS Consensus Estimate: $0.48 EPS
  • Next Year EPS Consensus Estimate: $0.61 EPS
Additional Links:
Repligen Corp. (NASDAQ:RGEN) Chart for Friday, July, 29, 2016